Drug-induced extrapyramidal disorders - a neuropsychiatric interface.
In psychiatric literature, the term extrapyramidal syndrome has traditionally encompassed a wide variety of drug-induced movement disorders. Recently, it has become increasingly clear that the natural history, pathophysiology, and pharmacology of individual movement disorders are distinct, making this unifying term obsolete and, in fact, a source of confusion. The topic of drug-induced movement disorders is reviewed, and a classification system based on anatomy, pharmacology, and therapeutic considerations is discussed.
D014150:Antipsychotic Agents / Q000009:adverse effects; D001480:Basal Ganglia Diseases / Q000139:chemically induced*; D002819:Chorea / Q000503:physiopathology; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy / Q000503:physiopathology*; D004421:Dystonia / Q000139:chemically induced; D005116:Extrapyramidal Tracts / Q000502:physiology; D006801:Humans; D010300:Parkinson Disease / Q000503:physiopathology; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D011954:Receptors, Dopamine / Q000502:physiology
D014150:Antipsychotic Agents; D011954:Receptors, Dopamine